ID   LECC_CALSE              Reviewed;         153 AA.
AC   P93114;
DT   12-AUG-2020, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   25-MAY-2022, entry version 78.
DE   RecName: Full=Jacalin-related lectin Calsepa {ECO:0000303|PubMed:10908718, ECO:0000303|PubMed:15299962, ECO:0000303|PubMed:26971576, ECO:0000303|PubMed:28748044, ECO:0000303|PubMed:28973127, ECO:0000303|PubMed:8955378, ECO:0000303|PubMed:9111143};
DE   AltName: Full=Agglutinin {ECO:0000303|PubMed:10908718, ECO:0000303|PubMed:14561768, ECO:0000303|PubMed:18266762, ECO:0000303|PubMed:32143591, ECO:0000303|PubMed:8955378, ECO:0000303|PubMed:9111143};
DE   AltName: Full=Mannose/maltose-specific lectin {ECO:0000303|PubMed:8955378};
OS   Calystegia sepium (Hedge bindweed) (Convolvulus sepium).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   asterids; lamiids; Solanales; Convolvulaceae; Convolvuleae; Calystegia.
OX   NCBI_TaxID=47519 {ECO:0000312|EMBL:AAC49564.1};
RN   [1] {ECO:0000312|EMBL:AAC49564.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND MASS SPECTROMETRY.
RC   TISSUE=Rhizome {ECO:0000303|PubMed:8955378,
RC   ECO:0000312|EMBL:AAC49564.1};
RX   PubMed=8955378; DOI=10.1016/s0014-5793(96)01211-2;
RA   Van Damme E.J., Barre A., Verhaert P., Rouge P., Peumans W.J.;
RT   "Molecular cloning of the mitogenic mannose/maltose-specific rhizome lectin
RT   from Calystegia sepium.";
RL   FEBS Lett. 397:352-356(1996).
RN   [2]
RP   PROTEIN SEQUENCE OF 6-25 AND 75-94, FUNCTION, ACTIVITY REGULATION, SUBUNIT,
RP   TISSUE SPECIFICITY, AND BIOTECHNOLOGY.
RX   PubMed=9111143; DOI=10.1023/a:1018502107707;
RA   Peumans W.J., Winter H.C., Bemer V., Van Leuven F., Goldstein I.J.,
RA   Truffa-Bachi P., Van Damme E.J.;
RT   "Isolation of a novel plant lectin with an unusual specificity from
RT   Calystegia sepium.";
RL   Glycoconj. J. 14:259-265(1997).
RN   [3]
RP   CRYSTALLIZATION, SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=15299962; DOI=10.1107/s0907444996010955;
RA   Wright L.M., Wood S.D., Reynolds C.D., Rizkallah P.J., Van Damme E.J.,
RA   Peumans W.J.;
RT   "Crystallization and preliminary X-ray analysis of a novel plant lectin
RT   from Calystegia sepium.";
RL   Acta Crystallogr. D 53:220-221(1997).
RN   [4]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10908718; DOI=10.1016/s0014-5793(00)01801-9;
RA   Peumans W.J., Hause B., Van Damme E.J.;
RT   "The galactose-binding and mannose-binding jacalin-related lectins are
RT   located in different sub-cellular compartments.";
RL   FEBS Lett. 477:186-192(2000).
RN   [5]
RP   FUNCTION, AND SUBSTRATE SPECIFICITY.
RX   PubMed=18266762; DOI=10.1111/j.1742-4658.2008.06282.x;
RA   Nakamura-Tsuruta S., Uchiyama N., Peumans W.J., Van Damme E.J., Totani K.,
RA   Ito Y., Hirabayashi J.;
RT   "Analysis of the sugar-binding specificity of mannose-binding-type Jacalin-
RT   related lectins by frontal affinity chromatography--an approach to
RT   functional classification.";
RL   FEBS J. 275:1227-1239(2008).
RN   [6]
RP   BIOTECHNOLOGY.
RX   PubMed=28748044; DOI=10.1080/20002297.2017.1345581;
RA   Tawakoli P.N., Neu T.R., Busck M.M., Kuhlicke U., Schramm A., Attin T.,
RA   Wiedemeier D.B., Schlafer S.;
RT   "Visualizing the dental biofilm matrix by means of fluorescence lectin-
RT   binding analysis.";
RL   J. Oral Microbiol. 9:1345581-1345581(2017).
RN   [7]
RP   BIOTECHNOLOGY.
RX   PubMed=32143591; DOI=10.1186/s12885-020-6699-5;
RA   Takayama H., Ohta M., Iwashita Y., Uchida H., Shitomi Y., Yada K.,
RA   Inomata M.;
RT   "Altered glycosylation associated with dedifferentiation of hepatocellular
RT   carcinoma: a lectin microarray-based study.";
RL   BMC Cancer 20:192-192(2020).
RN   [8] {ECO:0007744|PDB:1OUW}
RP   X-RAY CRYSTALLOGRAPHY (1.37 ANGSTROMS) OF 2-153, FUNCTION, SUBSTRATE
RP   SPECIFICITY, SUBUNIT, TISSUE SPECIFICITY, ACETYLATION AT ALA-2, CIRCULAR
RP   DICHROISM ANALYSIS, AND 3D-STRUCTURE MODELING IN COMPLEX WITH
RP   CARBOHYDRATES.
RX   PubMed=14561768; DOI=10.1074/jbc.m308218200;
RA   Bourne Y., Roig-Zamboni V., Barre A., Peumans W.J., Astoul C.H.,
RA   Van Damme E.J., Rouge P.;
RT   "The crystal structure of the Calystegia sepium agglutinin reveals a novel
RT   quaternary arrangement of lectin subunits with a beta-prism fold.";
RL   J. Biol. Chem. 279:527-533(2004).
RN   [9] {ECO:0007744|PDB:5AV7}
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 3-153 IN COMPLEX WITH BISECTED
RP   BIANTENNARY GLYCAN, FUNCTION, AND SUBSTRATE SPECIFICITY.
RX   PubMed=26971576; DOI=10.1038/srep22973;
RA   Nagae M., Kanagawa M., Morita-Matsumoto K., Hanashima S., Kizuka Y.,
RA   Taniguchi N., Yamaguchi Y.;
RT   "Atomic visualization of a flipped-back conformation of bisected glycans
RT   bound to specific lectins.";
RL   Sci. Rep. 6:22973-22973(2016).
RN   [10] {ECO:0007744|PDB:5XFI}
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) IN COMPLEX WITH NON-BISECTED
RP   BIANTENNARY GLYCAN, FUNCTION, AND SUBSTRATE SPECIFICITY.
RX   PubMed=28973127; DOI=10.1093/glycob/cwx081;
RA   Nagae M., Mishra S.K., Hanashima S., Tateno H., Yamaguchi Y.;
RT   "Distinct roles for each N-glycan branch interacting with mannose-binding
RT   type Jacalin-related lectins Orysata and Calsepa.";
RL   Glycobiology 27:1120-1133(2017).
CC   -!- FUNCTION: Mannose-binding lectin (PubMed:9111143, PubMed:18266762,
CC       PubMed:14561768, PubMed:26971576, PubMed:28973127). Preferentially
CC       binds mannose at concentrations ranging between 5 and 25 mM, but binds
CC       also glucose. Has a marked preference for methylated sugar derivatives,
CC       such as alpha-MeMan and alpha-MeGlc, at concentration down to 5 mM
CC       (PubMed:14561768). Binds to N-glycans, but not to glycolipid-type or
CC       other type of glycans (PubMed:28973127). Binds N-linked high-mannose-
CC       type glycans (PubMed:18266762, PubMed:28973127). Has a preference for
CC       smaller (Man(2)-Man(6)) high-mannose-type glycans to larger (Man(7)-
CC       Man(9)) ones. Recognizes both alpha1-6 extended and alpha1-3 extended
CC       monoantennary glycans. The addition of alpha1-2Man to the Man-alpha1-
CC       3Man-beta branch results in a significant loss of affinity, but beta1-
CC       2GlcNAc has some affinity. Has less affinity for biantennary glycans
CC       (PubMed:18266762). However, affinity is significant for the biantennary
CC       complex-type N-glycans with bisecting GlcNAc (PubMed:18266762,
CC       PubMed:26971576, PubMed:28973127). No affinity is observed for tri- and
CC       tetra-antennary glycans (PubMed:18266762). Binds bisected glycans of
CC       the mouse brain. Selectively binds to bisecting N-glycans which are in
CC       back-fold conformation, and does not favor a glycan with an extend
CC       conformation (PubMed:26971576). Has hemagglutinating activity against
CC       rabbit erythrocytes at 0.3 ug/ml and against trypsin-treated human
CC       erythrocytes at 5 ug/ml. Has mitogenic activity in murine cells
CC       (PubMed:9111143). {ECO:0000269|PubMed:14561768,
CC       ECO:0000269|PubMed:18266762, ECO:0000269|PubMed:26971576,
CC       ECO:0000269|PubMed:28973127, ECO:0000269|PubMed:9111143}.
CC   -!- ACTIVITY REGULATION: Hemagglutinating activity is most inhibited by
CC       methyl alpha-mannopyranoside. This activity is inhibited to a less
CC       extent (about a third of the inhibition of that of methyl alpha-
CC       mannopyranoside) by methyl alpha-glucoside, other alpha-glucosides,
CC       such as maltose, isomaltose, panose or palatinose, and alpha-glucosides
CC       modified at the second position, such as methyl 2-deoxy-alpha-
CC       arabinoglucopyranoside or methyl 2-acetamido-2-deoxy alpha-
CC       glucopyranoside. Mildly inhibited by free monosaccharides, with glucose
CC       presenting at least 20-fold less inhibitory effect on hemagglutinating
CC       activity than mannose. Glycoproteins are somewhat inhibitory, the best
CC       being asialothyroglobulin and ovomucoid. Not inhibited by isomaltitol,
CC       sucrose or trehalose. {ECO:0000269|PubMed:9111143}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:14561768,
CC       ECO:0000269|PubMed:15299962, ECO:0000269|PubMed:9111143}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10908718}.
CC   -!- TISSUE SPECIFICITY: Rhizome (at protein level) (PubMed:8955378,
CC       PubMed:9111143, PubMed:15299962, PubMed:10908718, PubMed:14561768).
CC       Detected in the cortex and the pith of rhizome. Not detected in
CC       vascular tissues, pericycle, endodermis or rhizodermis
CC       (PubMed:10908718). {ECO:0000269|PubMed:10908718,
CC       ECO:0000269|PubMed:14561768, ECO:0000269|PubMed:15299962,
CC       ECO:0000269|PubMed:8955378, ECO:0000269|PubMed:9111143}.
CC   -!- PTM: Not glycosylated. {ECO:0000269|PubMed:9111143}.
CC   -!- MASS SPECTROMETRY: Mass=16092; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:8955378};
CC   -!- BIOTECHNOLOGY: Can be used for the isolation of glycoproteins from
CC       humans, plants and fungi. Is a powerful T-cell mitogen in the mouse,
CC       and can thus be used as an alternative to concanavalin A for the
CC       mitogenic proliferation of murine lymphocytes (PubMed:9111143).
CC       Identified as one of the several suitable fluorescently labeled lectins
CC       that can be used in a combination for the visualization and
CC       quantification of extracellular glycoconjugates in dental supragingival
CC       biofilms grown for 48 hours in situ in the absence of dietary
CC       carbohydrates (PubMed:28748044). Used in lectin-based microarrays to
CC       detect altered glycosylation in cancer tissue (PubMed:32143591).
CC       {ECO:0000269|PubMed:28748044, ECO:0000269|PubMed:32143591,
CC       ECO:0000269|PubMed:9111143}.
CC   -!- SIMILARITY: Belongs to the jacalin lectin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01088, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U56820; AAC49564.1; -; mRNA.
DR   PDB; 1OUW; X-ray; 1.37 A; A/B/C/D=2-153.
DR   PDB; 5AV7; X-ray; 1.85 A; A/B/C/D=3-153.
DR   PDB; 5XFI; X-ray; 1.65 A; A/B=1-153.
DR   PDBsum; 1OUW; -.
DR   PDBsum; 5AV7; -.
DR   PDBsum; 5XFI; -.
DR   AlphaFoldDB; P93114; -.
DR   SMR; P93114; -.
DR   UniLectin; P93114; -.
DR   EvolutionaryTrace; P93114; -.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IDA:UniProtKB.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IDA:UniProtKB.
DR   GO; GO:0005536; F:glucose binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0005537; F:mannose binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IDA:UniProtKB.
DR   GO; GO:0045840; P:positive regulation of mitotic nuclear division; IDA:UniProtKB.
DR   CDD; cd09612; Jacalin; 1.
DR   Gene3D; 2.100.10.30; -; 1.
DR   InterPro; IPR001229; Jacalin-like_lectin_dom.
DR   InterPro; IPR033734; Jacalin-like_lectin_dom_plant.
DR   InterPro; IPR036404; Jacalin-like_lectin_dom_sf.
DR   Pfam; PF01419; Jacalin; 1.
DR   SMART; SM00915; Jacalin; 1.
DR   SUPFAM; SSF51101; SSF51101; 1.
DR   PROSITE; PS51752; JACALIN_LECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing; Lectin.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   CHAIN           2..153
FT                   /note="Jacalin-related lectin Calsepa"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000450439"
FT   DOMAIN          6..152
FT                   /note="Jacalin-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01088"
FT   REGION          17..18
FT                   /note="N-glycan binding"
FT                   /evidence="ECO:0000269|PubMed:26971576,
FT                   ECO:0000269|PubMed:28973127, ECO:0007744|PDB:5AV7,
FT                   ECO:0007744|PDB:5XFI"
FT   REGION          95..96
FT                   /note="N-glycan binding"
FT                   /evidence="ECO:0000269|PubMed:26971576,
FT                   ECO:0000269|PubMed:28973127, ECO:0007744|PDB:5AV7,
FT                   ECO:0007744|PDB:5XFI"
FT   REGION          140..144
FT                   /note="N-glycan binding"
FT                   /evidence="ECO:0000269|PubMed:26971576,
FT                   ECO:0000269|PubMed:28973127, ECO:0007744|PDB:5AV7,
FT                   ECO:0007744|PDB:5XFI"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:14561768,
FT                   ECO:0007744|PDB:1OUW"
FT   STRAND          7..13
FT                   /evidence="ECO:0007829|PDB:1OUW"
FT   STRAND          17..23
FT                   /evidence="ECO:0007829|PDB:1OUW"
FT   STRAND          30..36
FT                   /evidence="ECO:0007829|PDB:1OUW"
FT   TURN            37..40
FT                   /evidence="ECO:0007829|PDB:1OUW"
FT   STRAND          41..50
FT                   /evidence="ECO:0007829|PDB:1OUW"
FT   STRAND          56..62
FT                   /evidence="ECO:0007829|PDB:1OUW"
FT   STRAND          71..76
FT                   /evidence="ECO:0007829|PDB:1OUW"
FT   STRAND          83..93
FT                   /evidence="ECO:0007829|PDB:1OUW"
FT   STRAND          96..108
FT                   /evidence="ECO:0007829|PDB:1OUW"
FT   STRAND          110..115
FT                   /evidence="ECO:0007829|PDB:1OUW"
FT   STRAND          119..123
FT                   /evidence="ECO:0007829|PDB:1OUW"
FT   STRAND          131..151
FT                   /evidence="ECO:0007829|PDB:1OUW"
SQ   SEQUENCE   153 AA;  16063 MW;  D94A5F2A8FED39AE CRC64;
     MAVPMDTISG PWGNNGGNFW SFRPVNKINQ IVISYGGGGN NPIALTFSST KADGSKDTIT
     VGGGGPDSIT GTEMVNIGTD EYLTGISGTF GIYLDNNVLR SITFTTNLKA HGPYGQKVGT
     PFSSANVVGN EIVGFLGRSG YYVDAIGTYN RHK
//
